25S.16 運用清冠一號於COVID-19病例報告
TJ TCM.25(S) : 137-148, 2022
|
運用清冠一號於COVID-19 病例報告
Taiwan Chingguan Yihau (NRICM101) for Severe COVID-19 Pneumonia: A Case Report
|
|
沈欣儀1 柯君頤1 陳星諭1* 陳俊良1
1 桃園長庚紀念醫院中醫部，桃園，台灣
|
|
【摘要】
|
|
新冠肺炎於2019 年底爆發，並因其極高的傳染力快速席捲全球，台灣亦於今年五月起經歷一波大規模的本土感染。快速增加的確診個案迫使醫師必須盡快分辨危急及輕症病患，以確保醫療資源能達最大效率使用。另在高度傳染性疾病的威脅下，傳統中醫望聞問切四診合參的診治模式受到限制，在疫情下如何參與疾病防治為當前主要議題。本病案為一68 歲有多重慢性疾病之男性，因發燒、呼吸困難至急診求助，經篩檢後確診為新冠肺炎患者，並因慢性疾病及初起一般空氣下氧氣飽和度93% 被歸類為重症病患，初始藥物包括類固醇、Interleukin-6 Inhibitors（IL-6 inhibitor）、抗生素及Remdesivir，並於入住加護病房時接受清冠一號合併治療。患者於住院隔日即退燒，十日內症狀緩解而出院返家隔離。藉由此病案我們將討論清冠一號在此類患者之適用性。
|
|
【關鍵詞】新冠肺炎、新冠肺炎重症、清冠一號、病例報告
|
|
Hsin-Yi Shen1Chun-Yi Ke1Hsing-Yu Chen1*Jiun-Liang Chen1
1Department of Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan Branch,
Taoyuan, Taiwan
|
|
【Summary】
|
|
The COVID-19 pneumonia broke out at the end of 2019 and rapidly swept the world due to its extremely high infectivity. Taiwan also suffered from COVID-19 epidemic since this May. The epidemic forced the physicians to identify severe, moderate, and mild patients as soon as possible to ensure that medical resources can be used with maximum efficiency. In addition, we should think about the ways to participate in disease control under the threat of highly contagious diseases with inappropriate traditional Chinese medicine diagnosis model of Wang, Wen, Wen, Qi. This case was a 68-year-old man with multiple chronic diseases. He went to the emergency room for fever and dyspnea. After screening, he was diagnosed as COVID-19 pneumonia. He was classified as a severe case since his had chronic diseases and the initial oxygen saturation in the room air was 93%. The treatment of severe cases included steroids, Interleukin-6 Inhibitors (IL-6 inhibitor), antibiotics and Remdesivir, and the patient received combined treatment with Taiwan Chingguan Yihau (NRICM101) when admitted to the intensive care unit. Fever subsided the next day after being hospitalized, and the symptoms were all improved within 10 days. With this case, we will discuss the applicability of NRICM101 in COVID-19 pneumonia patients.
【Keywords】COVID-19 pneumonia; Severe COVID-19 infection; Taiwan Chingguan Yihau (NRICM101); Case report
|
